Tag: Food and Drug Administration
Peanut allergy therapy receives $12M boost from Breakthrough Victoria
The Victorian Government announced a $12 million investment in Aravax, a local biotechnology firm, in a push to revolutionise peanut allergy treatment.
4DMedical gets US FDA green light clearance for CT-based ventilation product
Respiratory imaging technology company 4DMedical Limited announced the receipt of clearance from the US Food and Drug Administration (FDA) for its CT-based ventilation product CT LVAS.
Featured Article
Australian Manufacturing Week 2026 enters final run-up to Brisbane debut
Australia’s manufacturing sector continues to play a critical role in the national economy, underpinned by ongoing investment in advanced technologies, automation, and high-value production.
